chrisvoncsefalvay/vaers-outcomes huggingface dataset:
HEADACHE; MIGRAINE AND FELT LIKE BACK OF HEAD WAS GOING TO EXPLODE; FELT LIKE CRAP; FELT LIKE HAD BEEN HIT BY TRUCK; LEFT CALF PAIN; This spontaneous report received from a patient concerned a 53 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included thyroid disorder, addison diseases, leiden factor v, and steroids. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced migraine and felt like back of head was going to explode. On APR-2021, the subject experienced felt like crap. On APR-2021, the subject experienced felt like had been hit by truck. On APR-2021, the subject experienced left calf pain. Laboratory data included: Pain scale (NR: not provided) 5 and 10. Treatment medications included: acetylsalicylic acid, eugenol/menthol/methyl salicylate, and rizatriptan. On 07-APR-2021, the subject experienced headache. Additional treatment medications (dates unspecified) included: gabapentin. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from migraine and felt like back of head was going to explode, felt like crap, felt like had been hit by truck, left calf pain, and headache on APR-2021. This report was non-serious.
SIDE EFFECTS; This spontaneous report received from a patient via a company representative via social media concerned a patient of unspecified age, sex, race and ethnic origin. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry were not reported) dose, start therapy date were not reported, 01 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced side effects, and ended up in [name redacted] at hospital for 2 days. Horrible. Discharge information was not reported. As per the patient, "[Name redacted] I had side effects ended up in [name redacted] at hospital for 2 days... horrible.. ". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of side effects was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20221222838-side effects. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable.
fever of 101F° after the second vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 101F° after the second vaccine) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever of 101F° after the second vaccine). At the time of the report, PYREXIA (fever of 101F° after the second vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101f° (High) 101F°.         Concomitant medications details were not reported by the reporter  Treatment details was not reported by the reporter.    This case was linked to MOD-2021-398470 (Patient Link).
exhaustion and brain fog have remained for almost two weeks; Swollen glands under right armpit and both sides of neck/ chin; exhaustion and brain fog have remained for almost two weeks; Dose 1 on 02Apr2021 and Dose 2 on 04Apr2021; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 04Apr2021 (Lot number: EIN0151) at the age of 38 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Antibiotics, reaction(s): "known allergies: antibiotics". Vaccination history included: Bnt162b2 (dose 1, lot number= FR8734, vaccine location= Left arm), administration date: 02Apr2021, when the patient was 38 years old, for COVID-19 Immunization, reaction(s): "Swollen glands under left armpit". The following information was reported: FEELING ABNORMAL (non-serious), FATIGUE (non-serious) all with onset 04Apr2021, outcome "not recovered" and all described as "exhaustion and brain fog have remained for almost two weeks"; LYMPHADENOPATHY (non-serious) with onset 04Apr2021, outcome "not recovered", described as "Swollen glands under right armpit and both sides of neck/ chin"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 04Apr2021, outcome "unknown", described as "Dose 1 on 02Apr2021 and Dose 2 on 04Apr2021". The events "exhaustion and brain fog have remained for almost two weeks", "swollen glands under right armpit and both sides of neck/ chin" and "exhaustion and brain fog have remained for almost two weeks" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of feeling abnormal, lymphadenopathy, fatigue.  Additional Information: It was reported that no other vaccines were given in four weeks. The patient did not have Covid prior vaccination. The patient had not tested for Covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Rash on the right arm; This case was reported by a other health professional via sales rep and described the occurrence of rash in a 72-year-old female patient who received Herpes zoster (Shingrix) (batch number JN25B, expiry date 9th November 2021) for prophylaxis.   The patient's past medical history included shingles (on right leg). Previously administered products included Shingrix (1st dose received on 27th March 2019).   On an unknown date, the patient received the 2nd dose of Shingrix .5 ml. On 18th April 2020, less than a year after receiving Shingrix, the patient experienced rash. The patient was treated with valaciclovir hydrochloride (Valtrex) and  (Triamscinalone ointment). On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the second dose from a pharmacy and the practice did not have the date when the 2nd dose was administered.  The patient began experiencing a rash on the right arm on Saturday April 18th and sought medical treatment from her physician office through a virtual visit on Monday April 20th. The patient was prescribed Valtrex and Triamscinalone ointment.  No further follow up or treatment done.
Mom reported pt had t104 which started 11PM 5AUG91, lasted until Tuesday; Fever resolved w/use of APAP; On 7AUG91 devel spot like rash on face & arms; Resolved itself the following day; MD notified of events;
sore arm and only sore to touch; A spontaneous report was received from a consumer concerning her husband, a male patient of an unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a little sore arm that was only sore to touch/vaccination site pain.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 21 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 030L20A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On an unknown date, post receiving the vaccine the patient experienced a little sore arm that was only sore to touch and lasted about a day. Treatment information was unknown.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the event, a little sore arm that was only sore to touch was resolved at the time of this report.
Greatly exacerbated gout flare; Pain; Swelling; Redness; Hot to touch; Fluid build up in his left knee; Arm sensitivity; Increased left knee pain; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (Greatly exacerbated gout flare), PAIN (Pain), SWELLING (Swelling), ERYTHEMA (Redness) and FEELING HOT (Hot to touch) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gout flare (Moderate) from 20-Feb-2021 to 13-Mar-2021. Concurrent medical conditions included Gout since 2010, Asthma since 1980, Psoriasis since 1950, Kidney function abnormal (Reduced kidney function.) since 1970, Osteo arthritis knees (Increased left knee pain) since 2000, Wood dust allergy, Grass allergy, Pollen allergy, Dust allergy and Allergy to animal dander (Cat dander.). Concomitant products included APIUM GRAVEOLENS SEED, BROMELAINS, CURCUMA LONGA ROOT, POTASSIUM CITRATE, PRUNUS SEROTINA FRUIT (GO OUT PLEX) for Gout flare, ZYFLAMEND for Inflammation, VITAMIN D3, PROBIOTICS NOS and VITAMIN B COMPLEX for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN (Pain), SWELLING (Swelling), ERYTHEMA (Redness), FEELING HOT (Hot to touch), SYNOVIAL DISORDER (Fluid build up in his left knee), VACCINATION SITE PAIN (Arm sensitivity) and ARTHRALGIA (Increased left knee pain). On 26-Feb-2021, the patient experienced GOUT (Greatly exacerbated gout flare). The patient was treated with PREDNISONE (oral) on 01-Mar-2021 for Gout flare, at a dose of Day 4: 20 mg.day 5 :15 mg, day 6 and 7 :10 mg, day 8:7.5 mg and day 9: 2.5 mg. On 13-Mar-2021, GOUT (Greatly exacerbated gout flare) had resolved. At the time of the report, PAIN (Pain), SWELLING (Swelling), ERYTHEMA (Redness), FEELING HOT (Hot to touch), SYNOVIAL DISORDER (Fluid build up in his left knee), VACCINATION SITE PAIN (Arm sensitivity) and ARTHRALGIA (Increased left knee pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 02-Apr-2021 at 1:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) (batch no. 031A21A) for dosage on left upper arm.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Follow up received on 02-May-2021 contains added patient demographics, medical history and concomitants, treatment, added vaccine information and added event.The outcome of the event gout changed from unknown to recovered.
Rash/Hives around the face area. Eczema patches on the body.
So much fever; Chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (So much fever), CHILLS (Chills) and MYALGIA (Body aches) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced PYREXIA (So much fever) and CHILLS (Chills). 12-Mar-2021, the patient experienced MYALGIA (Body aches). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PYREXIA (So much fever), CHILLS (Chills) and MYALGIA (Body aches) had resolved.            No concomitant medications were reported.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.   This case was linked to MOD-2021-043050 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow-up was received on 05-MAY-2021. All reported event outcomes were updated to recovered/resolved.
Had a rash with itching I had a prescription from Dr for Itching what I got a shot  of steroids once my God
Received vaccine in left arm 05/22/2012. Returned to pharmacy 5-24-12 redness amongst 80% of upper arm. Center (vaccination site) begin to blister. Warm to touch. Pt. reported tingling day before and now pain. Redness continued to spread. Referred to physician. Determined as "shingles outbreak" treated with antiviral.
71-year-old female who presents to the emergency department by ambulance for weakness and tingling to hands and feet.  Patient was seen 1 week ago in the emergency department for abdominal pain and she was diagnosed with a UTI at that time, she was put on Keflex.  Her sister and her son had noticed that she is not taking her medication and 2 days ago they restarted her Keflex and she denies any urinary symptoms at this time.  Patient states that she has had some abdominal bloating, she is a former heavy drinker and stopped drinking around Christmas time.  In a prior note she has had these paresthesias to her hands and legs over the last week so this is not a new complaint.  Patient is a smoker and past surgical history is tonsillectomy.  She states that she has not walked in the last several days because of the paresthesias in her feet and she feels too weak to get out of the chair, she is only drinking Ensure for nutrition.  Her son lives out of town and he is here today very concerned that she is not able to take care of herself.  She is also had some intermittent confusion over the last several weeks. Associated Symptoms: cough, fatigue, weakness
feeling fatigued; achy; light case of the common cold; This is a spontaneous report from a contactable consumer (patient). A 25-years-old male patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number EL3247; expiration date were not reported),  via unspecified route (administered in left arm)  at the age of 25-years-old, on 27Jan2021 08:45 AM as single dose for COVID-19 immunization. Patient's medical history and concomitant medications were not reported. The patient didn't had covid prior vaccination and didn't take covid test post vaccination. The patient experienced feeling fatigued, achy and light case of the common cold on 28Jan2021 10:00 AM. No treatment was received for the events. The outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
So what I had was I got  dizziness, shortness of breath, I started to get really hot and sweaty. The pharmacist even stated i look like I was about to pass out. the pharmacist brought me back into the back and gave me a barf bag and I sat down on the floor. and gave me water. The pharmacist also gave me a piece of candy. The symptoms lasted about 30 mins and I was able to leave out and go home.
Mild erythema approximately 6 cm in diameter little to no warmth to site. No treatment necessary.
Shingles on right side of stomach and waist.  Shooting pain has stopped today.
Shortness of breath. Dyspnea and chest pain was ED diagnosis. CT scan clear, CXR clear, EKG clear. Blood clotting factors were high. Discharge instruction were to follow up with Cardiology on 4-16-2021
C/o dizziness while sitting in monitoring. EMS checked. Client felt hot, dizzy, nausea, increase sweating.   Heart monitor showed low pulse rate 30. IV started BS 82. Transported to ER.
The patient received the pediatric pfizer vaccine without being diluted first. Currently, no side effects have been reported.
Injected Arm Felt a little Heavy; 16-year-old son received the first dose of Moderna COVID-19; Sore Arm a little; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of LIMB DISCOMFORT (Injected Arm Felt a little Heavy), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16-year-old son received the first dose of Moderna COVID-19) and VACCINATION SITE PAIN (Sore Arm a little) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history not provided.).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced LIMB DISCOMFORT (Injected Arm Felt a little Heavy), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16-year-old son received the first dose of Moderna COVID-19) and VACCINATION SITE PAIN (Sore Arm a little). On 18-Feb-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16-year-old son received the first dose of Moderna COVID-19) had resolved. On 20-Feb-2021, LIMB DISCOMFORT (Injected Arm Felt a little Heavy) had resolved and VACCINATION SITE PAIN (Sore Arm a little) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
I received dose 2 of the Moderna vaccine on the morning of Saturday 5/8. On Sunday afternoon, I developed a strange side effect where I experienced chest and upper abdominal pain. Sometimes it was expressed as just a discomforting tightness in the chest, but most noticeably it was expressed as a kind of stitch in the side kind of pain located in the center of the chest and in upper abdominals, between and right below the breasts. It wasn't chronic, but faded in and out depending on movement. This side effect was most acute for the latter half of Sunday and for all of Monday, 5/10. On Tuesday, 5/11 it had subsided enough that I felt I could resume my normal workout routine. On 5/11, I was able to complete my normal workout, even as some exercises (like standing crunches) made the chest pain/abdominal pain particularly acute. The most severe stretch of this symptom seems to be from that late Sunday through Tuesday afternoon. After that, faint traces of this chest pain could be felt through Thursday 5/13, but it wasn't as severe.
Dizziness, extreme muscle/joint pain, headache and fever with shivers shakes and chills.
localized reaction as expected - pain and swelling and redness at injection site - lowgrade fever and aching x 2 days   3rd night- severe hives and itching over torso, neck and arms - red and burning eyes and diminished vision - also some shortness of breath I am severely allergic to Sulfa drugs(including Neosporin ointment) - this is the exact reaction I have had to sulfa drugs - I have reviewed all the ingredients in this vaccine and do not see that sulfa is used - but I suspect otherwise - I am still having dramatic hives with new areas still forming and itching - making it difficult to maintain daily routine and wear clothing  - I will to back to emergency walk-in today to discuss additional treatments
Patient reported feeling numb and pain on left arm -> shoulder blade. Sx happened when patient walk out of the store but the shot was administered in right arm. Pt said no swelling, redness or rash at injection site. Reported this SE a month later after received the shot on 12/12/13.
Staff member of medical care facility given #2 of Hep B. series. Had rapid heart rate and hives(red, raised, itchy areas) around neck shortly after vaccine injection. Reported incident one hour after vaccination.  Sent to the local clinic where they administered 2 shots and sent her home.
FLU LIKE SYMPTOMS; NUMBNESS IN LIPS/MOUTH/TEETH; TWITCHING IN LEFT EYE; PAIN IN LEGS/PAIN DOWN TO FEET; NUMBNESS IN LEGS/FEET/FINGERTIPS/FACE/CHEEK/NOSE; This spontaneous report received from a consumer concerned a 51 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced numbness in legs/feet/fingertips/face/cheek/nose. On APR-2021, the subject experienced pain in legs/pain down to feet. Laboratory data included: Blood test (NR: not provided) unknown, Doppler scan (NR: not provided) unknown, and EKG (NR: not provided) unknown. On 08-APR-2021, the subject experienced flu like symptoms. On 08-APR-2021, the subject experienced numbness in lips/mouth/teeth. On 08-APR-2021, the subject experienced twitching in left eye. Treatment medications (dates unspecified) included: procaine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms on APR-2021, and the outcome of pain in legs/pain down to feet, numbness in legs/feet/fingertips/face/cheek/nose, numbness in lips/mouth/teeth and twitching in left eye was not reported. This report was non-serious.
Information has been received from a LPN concerning a physician in the office who on approx 10/31/05 was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot 651523/0604R. On approx 10/31/05, the physician experienced a more severe reaction than usual to the vaccine. The reaction included pain and swelling at the injection site. Unspecified medical attention was sought. Subsequently, the physician recovered. A investigation into the lot number was requested. No product quality complaint was involved. The records of testing prior to release of this lot have been checked and found to be satisfactory. The lot complies with the standards and was released. Additional information has been requested.
Patient received FLUVIRIN on 10-1-10. Patient called pharmacy on 10-5-10 and said her arm is very sore and she can not raise her arm. She said she has been icing her arm and that the arm is getting worse, not better. MD informed and wrote a prescription for Cephalexin.
Three hours post vax, the pt developed swelling, redness, soreness, and irritation. Eight hours post vax, the pt developed fever, chills, and he could hardly move. Twenty hours post vax, the chills were not as bad, but he could hardly move his arm and it was very hot at injection site. Forty-eight hours post vax, the arm was still swollen, red, hot, and sore.
He is experiencing a localized reaction that continues to grow. The redness and swelling are greater than 4 inches in diameter at this time.  No fever, no throat/eye swelling, denies itching (but mom did say patient is non verbal. Mom drew circle yesterday and it is expanding past circle by 1/2 inch on dorsal side of deltoid. Mom reports that there is a weird white halo around where the bandage was. They injection site looks  like an egg. injection was given at top of egg and then the redness spreads down from that. It is warm to the touch She has been giving him benadryl.
About 6 weeks after my second dose in February, I began to experience inflammation in various parts of my body.  It began with my knees.  I received cortisone shots.  I also needed a shot in my left hand for stiffness in my middle finger.  Then I began to experience pain in the nerve endings of my scalp also on the left side.  Yesterday, I had a Cath scan and am awaiting the results.